Population
Patients receiving coumarin-type anticoagulant therapy
Design
Review
Authors
Loading...
May guide coumarin monitoring with quality thromboplastin; leaves open prospective validation against modern INR standards.
The Quick prothrombin time is sufficient for monitoring coumarin-type anticoagulants provided that satisfactory thromboplastin is used.
Benson et al. (1968) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: